Hormone-refractory prostate cancer: Which Medications Are Safest? (179 Drugs Compared)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
179 medications are used for Hormone-refractory prostate cancer, with 14,819 combined adverse event reports. The most reported drugs for Hormone-refractory prostate cancer are ENZALUTAMIDE and RADIUM RA-223 DICHLORIDE.
14,819
Total Reports
179
Drugs Used
All Medications for Hormone-refractory prostate cancer Ranked by Safety Reports
| Drug | Brand | Reports | Deaths (all) | Hosp. (all) | Death Rate |
|---|---|---|---|---|---|
| ENZALUTAMIDE | Xtandi | 8,881 | 9,676 | 9,282 | 19.6% |
| RADIUM RA-223 DICHLORIDE | Xofigo | 1,615 | 964 | 1,232 | 20.0% |
| ABIRATERONE | Abiraterone Acetate | 1,378 | 7,180 | 8,816 | 20.8% |
| DOCETAXEL | Docetaxel | 674 | 6,068 | 13,463 | 9.3% |
| LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN | PLUVICTO | 579 | 1,461 | 545 | 13.6% |
| DAROLUTAMIDE | NUBEQA | 553 | 508 | 723 | 15.6% |
| CABAZITAXEL | Jevtana | 524 | 467 | 950 | 18.3% |
| PREDNISONE | prednisone | 474 | 22,555 | 57,772 | 14.2% |
| APALUTAMIDE | ERLEADA | 365 | 1,286 | 2,136 | 13.5% |
| OLAPARIB | Lynparza | 313 | 5,496 | 3,471 | 30.1% |
| LEUPROLIDE | Fensolvi | 262 | 11,858 | 10,499 | 16.7% |
| PREDNISOLONE | Prednisolone Sodium Phosphate | 241 | 13,159 | 32,883 | 16.3% |
| ATEZOLIZUMAB | Tecentriq Hybreza | 224 | 8,520 | 15,094 | 25.3% |
| CABOZANTINIB | - | 170 | 767 | 2,771 | 20.0% |
| PEMBROLIZUMAB | KEYTRUDA | 130 | 15,543 | 35,472 | 18.6% |
| DENOSUMAB | Bilprevda | 105 | 19,354 | 17,749 | 13.0% |
| DEGARELIX | FIRMAGON | 102 | 484 | 1,333 | 12.8% |
| CARBOPLATIN | Carboplatin | 97 | 12,544 | 35,869 | 14.9% |
| BICALUTAMIDE | Bicalutamide | 87 | 462 | 1,486 | 11.4% |
| DEXAMETHASONE | Dexamethasone Sodium Phosphate | 72 | 22,319 | 51,311 | 17.8% |
Most Reported Drugs for Hormone-refractory prostate cancer
#1 most reported
#2 most reported
#3 most reported